Moreover, the activation of the STING pathway in cancer is associated with increased CD4+ and CD8+ lymphocytic infiltration, and its activation promotes the migration of peripheral blood mononuclear cells by activating CXCL10 and CCL5 expression (17). Here, STING1 is linked to cancer.